The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors

M. Hoffmann, E. Koutsogiannouli, M. Skowron, Maria Pinkerneil, G. Niegisch, A. Brandt, S. Stepanow, H. Rieder, W. Schulz
{"title":"The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors","authors":"M. Hoffmann, E. Koutsogiannouli, M. Skowron, Maria Pinkerneil, G. Niegisch, A. Brandt, S. Stepanow, H. Rieder, W. Schulz","doi":"10.3233/BLC-160065","DOIUrl":null,"url":null,"abstract":"Background: Cell culture models of normal urothelial cells are important for studying differentiation, disease mechanisms and anticancer drug development. Beyond primary cultures with their limitations in lifespan, interindividual heterogeneity and supply, few conditionally immortalized cell lines with limited applicability due to partial transformation or impaired differentiation capacity are available. We describe characteristics of the new spontaneously immortalized cell line HBLAK derived from a primary culture of uroepithelial cells. Objective: To characterize utility and limitations of HBLAK cells as an urothelial cell culture model. Methods: Differentiation markers were investigated by immunofluorescence and RT-PCR, genetic changes by standard karyotyping, array-CGH, PCR, RT-PCR and exome sequencing; expression of p53 and p21 by Western blotting. Results: HBLAK cells proliferated for >50 passages without senescing. They expressed cytokeratins of basal urothelial cells. Terminal differentiation markers appeared only after induction of differentiation by specific protocols. The karyotype was stable, with few chromosomal changes, especially gains of chromosomes 5 and 20 and a chromosome 9p21 deletion resulting in p16INK4A loss. A C228T TERT promoter mutation was present, but no other mutation typical of urothelial carcinoma. TP53 was wild-type and the cell cycle was arrested in response to genomic stress. Conclusions: HBLAK cells retain some differentiation potential and respond to cytotoxic agents similar to normal urothelial cells, but contain genetic changes contributing to immortalization in urothelial tumors. HBLAK may be valuable for evaluating the tumor specificity of novel cancer drugs, but may also be applied as an urothelial in vitro carcinogenesis model.","PeriodicalId":290379,"journal":{"name":"Bladder Cancer (Amsterdam, Netherlands)","volume":"202 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"29","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bladder Cancer (Amsterdam, Netherlands)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/BLC-160065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 29

Abstract

Background: Cell culture models of normal urothelial cells are important for studying differentiation, disease mechanisms and anticancer drug development. Beyond primary cultures with their limitations in lifespan, interindividual heterogeneity and supply, few conditionally immortalized cell lines with limited applicability due to partial transformation or impaired differentiation capacity are available. We describe characteristics of the new spontaneously immortalized cell line HBLAK derived from a primary culture of uroepithelial cells. Objective: To characterize utility and limitations of HBLAK cells as an urothelial cell culture model. Methods: Differentiation markers were investigated by immunofluorescence and RT-PCR, genetic changes by standard karyotyping, array-CGH, PCR, RT-PCR and exome sequencing; expression of p53 and p21 by Western blotting. Results: HBLAK cells proliferated for >50 passages without senescing. They expressed cytokeratins of basal urothelial cells. Terminal differentiation markers appeared only after induction of differentiation by specific protocols. The karyotype was stable, with few chromosomal changes, especially gains of chromosomes 5 and 20 and a chromosome 9p21 deletion resulting in p16INK4A loss. A C228T TERT promoter mutation was present, but no other mutation typical of urothelial carcinoma. TP53 was wild-type and the cell cycle was arrested in response to genomic stress. Conclusions: HBLAK cells retain some differentiation potential and respond to cytotoxic agents similar to normal urothelial cells, but contain genetic changes contributing to immortalization in urothelial tumors. HBLAK may be valuable for evaluating the tumor specificity of novel cancer drugs, but may also be applied as an urothelial in vitro carcinogenesis model.
新的永生化尿路上皮细胞系HBLAK包含早期尿路上皮肿瘤典型的明确遗传畸变
背景:正常尿路上皮细胞的细胞培养模型对于研究其分化、发病机制和开发抗癌药物具有重要意义。除了原代培养在寿命、个体间异质性和供应方面的局限性之外,很少有因部分转化或分化能力受损而适用性有限的条件永生化细胞系。我们描述了从尿上皮细胞原代培养中获得的新的自发永生化细胞系HBLAK的特征。目的:探讨HBLAK细胞作为尿路上皮细胞培养模型的实用性和局限性。方法:采用免疫荧光和RT-PCR检测分化标志物,采用标准核型、阵列cgh、PCR、RT-PCR和外显子组测序检测遗传变化;Western blotting检测p53和p21的表达。结果:HBLAK细胞增殖>50代,无衰老。它们表达基底尿路上皮细胞的细胞角蛋白。最终分化标记只有在特定的诱导方案诱导分化后才会出现。核型稳定,染色体变化较少,特别是5号和20号染色体增加,9p21染色体缺失导致p16INK4A缺失。存在C228T TERT启动子突变,但没有其他典型的尿路上皮癌突变。TP53是野生型的,细胞周期因基因组应激而被阻滞。结论:HBLAK细胞保留了一定的分化潜力,并对类似于正常尿路上皮细胞的细胞毒性药物作出反应,但包含有助于尿路上皮肿瘤永生化的遗传变化。HBLAK可能对评估新型抗癌药物的肿瘤特异性有价值,但也可能作为尿路上皮体外癌变模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书